It is with pleasure that we release the February 2021 Market Rates Report for Interim Corporate Recruiters within the Bio-Pharma sector. The report covers the United Kingdom and Australian market places and the data is drawn from our key clients, contractors and contacts within the sector.
Highlights of the report include the standardisation of average days rates for Corporate Recruiters across the UK and Australia regions – largely due to the prevalence of home working (remote delivery of in-house recruitment services). Technical sourcing expertise (particularly within the Bio-Pharma and Technology sectors) is greatly valued – particularly where there is high demand and competition for talent – and therefore offers flexibility around where in-house services are delivered from. (Regional flexibility).
There is particular strength within the international Bio-Pharma sector (in terms of a return to almost normal hiring trends not seen since February 2020). Many of our Clients report a full program of planned recruitment during the 2021 calendar year together with a re-release of requisitions which may have been on hold during the second half of 2020. In addition, the rapid deployment of new technologies associated with the development of the COVID vaccines has resulted in other rapid international initiatives within the sector – bringing forward other research programs and drug trials.
We hope you find this edition of the Corporate Recruiters Bio-Pharma Market Rates Report of interest.
For your complimentary copy, use the form below to download it with no waiting!